JP2017519801A5 - - Google Patents

Download PDF

Info

Publication number
JP2017519801A5
JP2017519801A5 JP2017500885A JP2017500885A JP2017519801A5 JP 2017519801 A5 JP2017519801 A5 JP 2017519801A5 JP 2017500885 A JP2017500885 A JP 2017500885A JP 2017500885 A JP2017500885 A JP 2017500885A JP 2017519801 A5 JP2017519801 A5 JP 2017519801A5
Authority
JP
Japan
Prior art keywords
group
substituted
alkyl
compound
alkoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2017500885A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017519801A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2015/065870 external-priority patent/WO2016005577A1/en
Publication of JP2017519801A publication Critical patent/JP2017519801A/ja
Publication of JP2017519801A5 publication Critical patent/JP2017519801A5/ja
Withdrawn legal-status Critical Current

Links

JP2017500885A 2014-07-11 2015-07-10 犬糸状虫に対する駆虫薬の使用 Withdrawn JP2017519801A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP14176737 2014-07-11
EP14176737.6 2014-07-11
PCT/EP2015/065870 WO2016005577A1 (en) 2014-07-11 2015-07-10 Use of anthelmintic agents against dirofilaria immitis

Publications (2)

Publication Number Publication Date
JP2017519801A JP2017519801A (ja) 2017-07-20
JP2017519801A5 true JP2017519801A5 (enExample) 2018-07-26

Family

ID=51167759

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017500885A Withdrawn JP2017519801A (ja) 2014-07-11 2015-07-10 犬糸状虫に対する駆虫薬の使用

Country Status (7)

Country Link
US (1) US20170196854A1 (enExample)
EP (1) EP3166605A1 (enExample)
JP (1) JP2017519801A (enExample)
CN (1) CN106470683A (enExample)
AU (1) AU2015286635A1 (enExample)
BR (1) BR112017000520A2 (enExample)
WO (1) WO2016005577A1 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR111295A1 (es) 2017-03-20 2019-06-26 Forma Therapeutics Inc Composiciones de pirrolopirrol como activadores de piruvato quinasa (pkr)
JOP20190223A1 (ar) 2017-04-01 2019-09-26 Novartis Ag عملية لتحضير حمض 1-(4- ميثان سلفونيل -2- تراي فلورو ميثيل - بنزيل)-2- ميثيل -1h- بيرولو [2، 3-b] بيريدين -3- يل- أسيتيك
WO2020061255A1 (en) 2018-09-19 2020-03-26 Forma Therapeutics, Inc. Activating pyruvate kinase r
US20200129485A1 (en) 2018-09-19 2020-04-30 Forma Therapeutics, Inc. Treating sickle cell disease with a pyruvate kinase r activating compound
TWI767148B (zh) 2018-10-10 2022-06-11 美商弗瑪治療公司 抑制脂肪酸合成酶(fasn)
AU2019387370A1 (en) 2018-11-30 2021-06-10 Nuvation Bio Inc. Pyrrole and pyrazole compounds and methods of use thereof
US20200385398A1 (en) 2019-06-07 2020-12-10 Elanco Tiergesundheit Ag New bicyclic derivatives
MX2022003025A (es) 2019-09-19 2022-04-07 Forma Therapeutics Inc Activacion de la piruvato cinasa r.
EP4110336A4 (en) 2020-02-28 2024-06-05 Auburn University SIGNATURES OF DIROFILARIA VOLATILE ORGANIC COMPOUNDS AND THEIR USES
WO2021175155A1 (zh) * 2020-03-06 2021-09-10 广州再极医药科技有限公司 噻吩并嘧啶类衍生物及其制备方法
US12128035B2 (en) 2021-03-19 2024-10-29 Novo Nordisk Health Care Ag Activating pyruvate kinase R

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200938203A (en) * 2007-12-17 2009-09-16 Intervet Int Bv Anthelmintic agents and their use
TW201041868A (en) * 2009-03-20 2010-12-01 Intervet Int Bv Anthelmintic agents and their use
TW201111358A (en) * 2009-06-18 2011-04-01 Intervet Int Bv Anthelmintic agents and their use
EP2468096A1 (en) * 2010-12-21 2012-06-27 Intervet International BV Anthelmintic combinations
NZ716598A (en) * 2012-11-20 2017-02-24 Merial Inc Anthelmintic compounds and compositions and method of using thereof

Similar Documents

Publication Publication Date Title
JP2017519802A5 (enExample)
JP2016536364A5 (enExample)
JP2015535277A5 (enExample)
JP2006515858A5 (enExample)
JP2016536363A5 (enExample)
AR076258A1 (es) Agentes antihelminticos y su utilizacion
JP2013530176A5 (enExample)
JP2015522650A5 (enExample)
JP2016540742A5 (enExample)
MX2017010735A (es) Inhibidores de inhibidores del factor beta de crecimiento de transformacion (tgf-beta).
EA201690019A1 (ru) Производное аминотриазина и содержащая его фармацевтическая композиция
AR085585A1 (es) Vinil- y alquinilciclohexanoles sustituidos como principios activos contra estres abiotico de plantas
PE20160540A1 (es) Inhibidores de bromodominios
JP2011503103A5 (enExample)
RU2013144215A (ru) Средство для борьбы с эндопаразитами
RU2015121431A (ru) Замещенные производные индол-5-ола и их терапевтическое применение
AR069772A1 (es) Derivados heterociclicos, una composicion farmaceutica y un juego que los comprenden y su uso en la preparacion de un medicamento para el tratamiento de una infeccion parasitaria.
JP2016503797A5 (enExample)
ATE540037T1 (de) Triazolopyridine als phosphodiesterasehemmer zur behandlung von hautkrankheiten
EA201990902A1 (ru) Ингибиторы тирозинкиназы брутона
IN2014DN07283A (enExample)
EA201190119A1 (ru) ПРОИЗВОДНЫЕ ТРИАЗОЛОПИРИДИНА В КАЧЕСТВЕ ИНГИБИТОРОВ МАР-КИНАЗЫ p38
EA201600403A1 (ru) N-ацилиминогетероциклические соединения
AR086389A1 (es) Inhibidores del virus de la hepatitis c
JP2016505536A5 (enExample)